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Abstract
Diabetes mellitus predisposes the host to bacterial infections. Moreover, hyperglycemia has been shown to be an
independent risk factor for respiratory infections. The luminal surface of airway epithelia is covered by a thin layer of airway
surface liquid (ASL) and is normally sterile despite constant exposure to bacteria. The balance between bacterial growth and
killing in the airway determines the outcome of exposure to inhaled or aspirated bacteria: infection or sterility. We
hypothesized that restriction of carbon sources –including glucose– in the ASL is required for sterility of the lungs. We found
that airway epithelia deplete glucose from the ASL via a novel mechanism involving polarized expression of GLUT-1 and
GLUT-10, intracellular glucose phosphorylation, and low relative paracellular glucose permeability in well-differentiated
cultures of human airway epithelia and in segments of airway epithelia excised from human tracheas. Moreover, we found
that increased glucose concentration in the ASL augments growth of P. aeruginosa in vitro and in the lungs of
hyperglycemic ob/ob and db/db mice in vivo. In contrast, hyperglycemia had no effect on intrapulmonary bacterial growth
of a P. aeruginosa mutant that is unable to utilize glucose as a carbon source. Our data suggest that depletion of glucose in
the airway epithelial surface is a novel mechanism for innate immunity. This mechanism is important for sterility of the
airways and has implications in hyperglycemia and conditions that result in disruption of the epithelial barrier in the lung.
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Introduction
Hyperglycemia in both diabetic and non-diabetic patients is
associated with an increased risk of complications and mortality
from community acquired pneumonia [1–3]. Interestingly, in the
absence of hyperglycemia, diabetes itself does not increase these
risks [2–4]. A number of possible explanations for the association
between hyperglycemia and pulmonary infection exist, but the
mechanisms are still unknown.
The luminal surface of airway epithelia is covered by a thin
layer of fluid, termed the airway surface liquid (ASL) [5], and is
normally sterile despite frequent exposure to bacteria, fungi and
viruses. Inhaled and aspirated bacteria [6] are cleared upon
reaching this surface by mechanisms that include ASL antimicro-
bials, mucociliary clearance and other components of innate and
adaptive immunity. In addition to these antimicrobial compo-
nents, the ASL also contains factors that are required for bacterial
growth, such as electrolytes, proteins, lipids, amino acids and
oligo-/mono-saccharides, including glucose [7,8]. It has been
speculated that amino acid, peptide and sugar residue transporters
contribute to lung host defense by clearing these compounds from
the surface of the airways and alveoli and making them
unavailable to bacteria [8,9].
Recently, Baker et al. [10] showed that the concentration of
glucose in the ASL is increased in hyperglycemic non-diabetics
and diabetics, and in humans with cystic fibrosis (CF). In other
studies, the same group demonstrated that the detection of glucose
in bronchial aspirates of intubated patients correlated with the risk
of MRSA infection [11] and that glucose in the nasal secretions of
humans with CF-related diabetes facilitated growth of Staphylococ-
cus aureus and Pseudomonas aeruginosa [12]. In this study, we
hypothesized that restriction of carbon sources -specifically
glucose- in the ASL is an important component of innate
immunity. We report a mechanism responsible for a glucose
concentration gradient generated by human airway epithelia
resulting in low ASL glucose concentration, impaired bacterial
growth, and airway sterility.
Materials and Methods
For detailed materials and methods, see Supporting Methods in
Text S1.
Ethics Statement
Animal experiments were carried out in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
experiments were approved by the Animal Care and Use
Committee of the University of Iowa (ACURF # 1004078).
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Primary human airway epithelia were grown at the air-liquid
interface as previously described [13].
Transmission Electron Microscopy
Primary cultures of human airway epithelia were fixed using a
fluorocarbon-based protocol that allows preservation of the ASL
and mucus layer.
Collection of airway surface liquid (ASL)
ASL was collected from primary cultures of human airway
epithelia and glucose concentration was determined using a
glucose oxidase assay.
Measurement of transepithelial electrical properties of
intact human tracheal epithelia
Epithelia dissected from 3 human tracheas (obtained from the
University of Iowa In Vitro Models and Cell Culture Core) were
studied in Ussing chambers.
Microarray data analysis
A MIAME-compliant microarray dataset previously deposited
in GEO under accession #GSE20502 was used to determine the
mRNA expression profile of GLUT and SGLT transporters in
human airway epithelia in vivo and in vitro. For method details, see
GEO accession.
Immunocytochemistry
Primary cultures of HAE were immunostained and visualized
with confocal microscopy as described in [14]. For primary and
secondary antibodies, see Text S1. As controls, we studied epithelia
without primary antibody and isotype-matched control antibody.
Bidirectional fluxes and uptake of glucose
Bidirectional fluxes and uptake of radiolabeled L-glucose and 2-
deoxyglucose were done using glucose-free DMEM supplemented
with 5 mM of the corresponding non-radiolabeled and 0.5 mCi of
radiolabeled glucose analog.
Bacterial strains
The PAO1 strain of P. aeruginosa was used where indicated. The
edd
2 mutant was obtained from the UW P. aeruginosa Mutant
Library [15]. Adequate transposon insertion was confirmed by
PCR as indicated by providers of the strain.
P. aeruginosa growth in vitro
PAO1 was grown overnight in LB medium at 37uC. Bacteria
were centrifuged at 4uC for 15 min. at 32006g. and resuspended
in 50 mL M9 medium twice followed by dilution in M9 or ASL
pooled from 6 different donors, to an OD 0.05 at 600 nm. Glucose
was added as indicated. Samples were kept in a shaking incubator
at 300 rpm and 37uC, and OD 600 nm was determined at times
shown.
P. aeruginosa growth on cultures of human airway epithelia
The apical surface of cultures of human airway epithelia was
inoculated with PAO1 in a volume of 0.1 mL and bacteria were
quantified after 24 hours.
P. aeruginosa pulmonary challenge in mice
Sex-matched 22 to 24 week-old ob/ob and db/db mice and their
littermate controls were used. Intranasal inoculation with the
indicated bacterial strain was followed by quantification of
bacteria in lung homogenate after 6 hours.
Statistical analysis
Statistical analyses were performed in Graphpad Prism 5 for
MacOSX. Unpaired T-test was performed on every analysis
except in Figure 4, C and D, where a Z-test for proportions was
used and Figure 5, A and B, where Mann-Whitney U test for
nonparametric data was performed. A p-value ,0.05 was
considered statistically significant [16].
Results
Airway epithelia generate a transepithelial glucose
gradient
Studies of exhaled breath condensate have shown that the
glucose concentration in ASL is approximately one tenth that in
serum [10]. We hypothesized that the airway epithelium can
maintain a transepithelial glucose gradient. We collected ASL
from well-differentiated human airway epithelia cultures grown at
the air-liquid interface (Figure 1, A), and compared the glucose
concentration to that in the basolateral nutrient media. While the
basolateral glucose concentration was 16.660.4 mM, the concen-
tration in the ASL was 2.260.5 mM (Figure 1, B).
Na
+/glucose co-transporter activity is absent from airway
epithelia
Na
+-glucose co-transporters (SGLT-1 and SGLT-2) transport
glucose against a concentration gradient in intestinal, renal, and
lung alveolar epithelia [17,18]. Transport of glucose follows the
Na
+ gradient generated by the Na
+/K
+ ATPase pump. This
mechanism is capable of generating a current that can be
measured as a short circuit current (Isc) in Ussing chamber studies
[19]. We hypothesized that glucose depletion from the ASL occurs
through SGLT-mediated Na
+-glucose co-transport. Airway epi-
thelia dissected from human tracheas were mounted in Ussing
chambers for Isc measurements. Apical glucose concentration was
sequentially increased (Figure 2, A–B). Apical glucose did not
generate a change in Isc, in contrast to tissues that express Na
+-
Figure 1. Human airway epithelia maintain a transepithelial
glucose gradient. (A) Transmission electron microscopy of perfluor-
ocarbon-fixed cultures of human airway epithelia. Figure indicates
airway surface liquid (ASL), epithelial surface (ES) and filter membrane
support (FM). (B) Glucose concentration in ASL collected from cultures
of human airway epithelia was compared to glucose concentration in
basolateral nutrient media. Data shown as mean 6 s.e.m. n=6 samples
per group. (***: p,0.0001).
doi:10.1371/journal.pone.0016166.g001
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cells of rats) where, as previously shown, addition of glucose to the
apical surface results in a change in Isc [20,21]. Moreover, addition
of phlorizin, an SGLT blocker, did not result in a decrease in Isc,
further confirming absence of Na
+-glucose co-transport activity.
Complementary experiments were performed using well-differen-
tiated cultures of human airway epithelia (Figure S1) and results
are consistent with data from intact airway epithelia. These data
suggest that electrogenic Na
+-glucose co-transport is not the
mechanism that generates the transepithelial glucose gradient in
human airway epithelia.
Polarized expression of glucose transporters in human
airway epithelia
To identify glucose transporters in human airway epithelia, we
first performed a screening analysis of GLUT (glucose facilitated
diffusion proteins) and SGLT mRNA expression. We analyzed a
dataset (GEO Accession #GSE20502) derived from microarray
hybridizations with human in vivo and in vitro airway tissue
(Figure 2, C). The analysis revealed a high correlation between
expression levels of glucose transporters in vitro and in vivo
(R
2=0.81). We noticed high-level expression of GLUT-10 (Entrez
GeneID: 81031), which is encoded by a 5-exon gene, located on
chromosome 20. GLUT-10 mRNA has previously been detected
in lung tissue and is also expressed in the heart, brain, skeletal
muscle and placenta [22,23].
We then investigated the expression and localization of glucose
transporters in human airway epithelia by immunocytochemistry.
We found no expression of GLUT-2, GLUT-3, GLUT-4, GLUT-
8, SGLT-1 or SGLT-2. We detected GLUT-1 (Entrez GeneID:
6513) in the basolateral membrane (Figure 2, D), and GLUT-10
localized to the apical membrane of human airway epithelia
(Figure 2, E). These data suggest that expression of different
facilitated diffusion glucose transporters in the apical and
basolateral membranes of human airway epithelia may play a
role in generation of the transepithelial glucose concentration
gradient.
Bidirectional fluxes of glucose in human airway epithelia
The existence of a transepithelial glucose concentration gradient
in the absence of active sodium-coupled absorption suggests that
either 1) basolateral glucose supplied to the epithelial cells is
unable to reach the ASL through the paracellular or the
transcellular pathway, unlikely given that even in ‘‘tight epithelia’’,
paracellular permeability to small molecules is not 0 (the
paracellular pathway is dynamic) or 2) At equilibrium, the
transepithelial flux of glucose into ASL is balanced by an
absorptive process.
We first measured the bidirectional flux of
14C-L-glucose in
human airway epithelia. L-glucose is a stereoisomer of D-glucose
that allows determination of paracellular transport of glucose
because it is not a substrate for glucose transporter proteins. The
14C-L-glucose transport rate (Figure 3, A) was similar in both
directions (basolateral to apical =1.9060.09 nmoles/cm
2/h,
apical to basolateral =2.1960.24 nmoles/cm
2/h, p=0.24)
indicating paracellular permeability to glucose but no net
Figure 2. Human airway epithelia express GLUT-1 and GLUT-10. (A) Short-circuit current (Isc) in human bronchial epithelia was studied in
Ussing chambers. To maximize detection of SGLT-mediated sodium absorption, amiloride and GlyH were added to the apical buffer to block ENaC
and CFTR-mediated absorption of sodium and secretion of chloride, respectively, followed by glucose in increasing concentrations and phlorizin.
Each circle corresponds to one sample (11 total) obtained from 3 donors. Mean 6 s.e.m are shown (B) Representative Isc tracing from intact human
bronchial epithelia. (C) Microarray analysis of mRNA from in vivo and in vitro human airway tissue. Normalized expression levels of GLUT and SGLT
gene family members are shown. n=16 samples per group. (D and E) Cultures of human airway epithelia were immunostained using a GLUT-1 (D
green) or GLUT-10 (E, green) antibody. XY (top image) and XZ (bottom image) projections are shown. DAPI (nuclei) is shown in blue, E-cadherin
(intercellular junction) is shown in D (red), and acetylated alpha tubulin (cilia) is shown in E (red). Representative images from 3 experiments are
shown. Isotype-matched antibody and no-primary controls did not show fluorescence after staining. Scale bars, 10 mm.
doi:10.1371/journal.pone.0016166.g002
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we repeated the bidirectional flux assays using
14C-2-deoxyglucose
(
14C-2-DOG), a glucose analog that is a substrate for glucose
transporters and can also be phosphorylated by the intracellular
hexokinase activity of the airway epithelial cells [24]. Once
phosphorylated, glucose or 2-DOG cannot be transported across
the cell membrane. We found a basolateral to apical transport rate
(8.1560.52 nmoles/cm
2/h) and an apical to basolateral transport
rate (5.3560.38 nmoles/cm
2/h) (Figure 3, B) that were both
higher than that observed for paracellular transport. These results
indicate that glucose supplied to airway epithelia can reach the
ASL through both the paracellular and transcellular pathway. We
next hypothesized that the apical glucose uptake capacity would be
equal or greater than the net basolateral to apical transepithelial
flux of glucose.
Airway epithelia absorb glucose from the apical and
basolateral compartments
We conducted radiolabeled tracer uptake experiments in which
we measured the amount of glucose that entered the intracellular
compartment after addition to the apical or basolateral side of
well-differentiated cultures of human airway epithelia. Uptake of
14C-2-DOG per sample was 12.362.4 nmoles/cm
2/h after apical
addition and 80.864.8 nmoles/cm
2/h after basolateral addition
(Figure 3, C). These data show that in human airway epithelia,
both the apical and the basolateral membrane are permeable to
glucose and basolateral uptake occurs at a higher rate than apical
uptake of glucose. Therefore, although glucose can reach the ASL
through both the paracellular and transcellular pathways at a
specific rate, the epithelial cells have the capacity to absorb it
through the apical membrane at an equal or higher rate (Figure 3,
D). This would allow the presence of a transepithelial glucose
gradient at homeostasis and in the absence of Na
+-glucose co-
transport activity, as detailed in the discussion section. As a
comparison, we investigated glucose fluxes in ex vivo tracheal
epithelia from Sus scrofa (domestic pig) in Figure S2. The data
indicate that in ex vivo tracheal epithelia, glucose can reach the
ASL through the paracellular but not the transcellular pathway
and uptake occurs at both the apical and basolateral membranes.
These results are concordant with our in vitro data. We next studied
the physiological significance of this transepithelial glucose
gradient.
Low glucose concentration impairs bacterial growth in
ASL
Airway surface liquid contains multiple antimicrobials known to
play a role in innate immunity [7,25]. We hypothesized that the
low glucose concentration in ASL may result in an impaired
bacterial growth rate, favoring antimicrobial activity over bacterial
growth. We chose P. aeruginosa (strain PAO1) as a pathogen
because it can use multiple carbon sources for growth, including
glucose [26]. The concentration of glucose in minimal growth
media (M9) directly determined the growth rate of PAO1 in a
dose-dependent manner (Figure 4, A). When we inoculated ASL in
vitro (Figure 4, B), PAO1 grew only in the presence of 20 mM
glucose (mean OD at 24 h for ASL=0.23160.008 vs. mean OD
at 24 h for ASL + glucose=0.64360.012. p,0.0001). The growth
rate observed without added glucose is in the range seen in
minimal growth media with 0.5 to 2 mM glucose. These data
suggest that ASL does not contain a sufficient concentration of
carbon sources to support growth of P. aeruginosa.
Low glucose concentration impairs bacterial growth on
the airway surface in situ
Airway surface liquid kills bacteria using salt-sensitive peptides
such as lysozyme and defensins [7,25] that are efficient only
against small inoculum sizes [25,27]. An increased bacterial
growth rate in the presence of excess nutrient sources could
overwhelm this system by allowing the bacteria to reach the
threshold at which innate immune killing becomes ineffective. We
investigated the effect of glucose on the ability of PAO1 to grow on
the surface of human airway epithelia. We predicted that
increasing the glucose concentration in ASL would impair the
bactericidal activity against PAO1. We inoculated the apical
surface of human airway epithelia cultures from 5 different donors
with a PAO1 inoculum of 2.3 or 3.3 log CFU per group. As
previously shown [27], human airway epithelia can effectively kill
2.3 log CFU of P. aeruginosa but not 3.3 log CFU. Importantly,
when the inoculum and glucose were simultaneously applied to the
ASL, airway epithelia failed to kill even 2.3 log CFU of PAO1
(Figure 4, C). We then predicted that lack of apical glucose
transport would result in increased bacterial growth in ASL. While
human airway epithelia were able to effectively kill an inoculum of
up to 2.5 log CFU, preincubation with 5 mM apical glucose and
phloretin –an inhibitor of GLUT transporters– resulted in failure
to kill inoculums of 1.5 and 2.5 log CFU (Figure 4, D). These data
are consistent with our in vitro results and suggest that low glucose
concentration in ASL is important in preventing bacterial growth
on the airway surface.
Figure 3. Airway epithelia can deplete airway surface liquid
glucose. (A and B) Basolateral to apical (BL to AP) and apical to
basolateral (AP to BL) fluxes of L-[1-
14C]glucose (A) or 2-deoxy-d-
[1-
14C]glucose (B) were measured in cultures of human airway epithelia
over 1 hour. Data shown as mean 6 s.e.m. n=6 samples per group.
(***: p,0.0001, ns: p $ 0.05). (C) Basolateral (BL) and apical (AP) uptake
of 2-deoxy-d-[1-
14C]glucose (2-DOG) in cultures of human airway
epithelia were measured over 1 hour. Data shown as mean 6 s.e.m.
n=6 samples per group. (***: p,0.0001). (D) Data from Figures 3 A, B
and C are integrated into a model of glucose transport in human airway
epithelia. Data in nmol/h. Black solid arrow represents paracellular
diffusion of glucose. Gray solid arrows represent 2-DOG uptake capacity
across the apical (top) and basolateral (bottom) membranes. Dotted
arrows represent transcellular bidirectional fluxes of 2-DOG (adjusted by
subtracting corresponding L-glucose fluxes). GLUT-10 is present in the
apical membrane and GLUT-1 is present in the basolateral membrane.
Intracellular glucose (G) is phosphorylated by hexokinase (HK) for
subsequent glycolysis. G6P= glucose-6-phosphate.
doi:10.1371/journal.pone.0016166.g003
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mice
To test the significance of low glucose concentrations in the ASL
in vivo, we studied PAO1 growth in murine lungs. Collecting
undiluted ASL from mouse airways is technically challenging. It
has been shown [28] that attempts to collect ASL using filter paper
techniques result in submucosal liquid collection with little ASL
recovery. Therefore, to investigate the effect of hyperglycemia on
ASL innate immunity, we used three complementary approaches
that include two models of hyperglycemic mice and a mutant
strain of P. aeruginosa that cannot metabolize glucose.
First, we investigated the intrapulmonary growth of PAO1
(Figure 5, A) in ob/ob mice, which are genetically leptin deficient
and become hyperglycemic and obese [29–33]. An intranasal
inoculum of 7.69 log CFU of PAO1 was given to ob/ob mice
(serum glucose=20.764.7 mM) and their littermate controls
(serum glucose=5.761.2 mM). Bacterial counts in lung homog-
enates 6 hours after inoculation were higher in hyperglycemic ob/
ob mice than in controls (median log CFU/mg of lung tissue =
1.28 for ob/ob vs. 0 for control mice).
Second, since the observed differences in the previous
experiment could be a direct consequence of leptin deficiency,
we repeated the experiment (Figure 5, A) using db/db mice [30,34]
and their littermate controls. These mice are leptin-receptor
deficient and also become hyperglycemic and obese (serum
glucose=22.665.3 mM). Bacterial counts in lung homogenates
6 hours after inoculation were higher in hyperglycemic db/db mice
than in their littermate controls (median log CFU/mg of lung
tissue=2.3 for db/db vs. 0.35 for control mice). The data from ob/
ob and db/db mice show that the bacterial counts are significantly
different between hyperglycemic and control mice (median log
CFU/mg of lung tissue=2.27, IQR 1.26 – 4.3 for hyperglycemic
mice vs. median=0.05, IQR 0 – 1.82 for control mice,
p=0.0176). The bacterial counts are not significantly different
when the db/db genotype is compared to the ob/ob genotype
(p=0.848) excluding leptin or leptin-receptor deficiency as the
cause of the difference in bacterial counts between control and
hyperglycemic mice.
Finally, we hypothesized that the higher susceptibility of
hyperglycemic mice to infection is caused by elevated concentra-
tions of glucose on the surface of the airway resulting in increased
availability of glucose as a nutrient source for bacteria. We
predicted that we would see no difference in bacterial growth if we
used a mutant of PAO1 incapable of metabolizing glucose. Some
artificially generated mutants [15] or clinical strains [12] of P.
aeruginosa show variability in their capacity to preferentially use
glucose as a carbon source, allowing to specifically assess the role
of glucose in bacterial growth in vivo. We repeated the experiment
using a transposon insertion mutant of PAO1 [15] with a defective
edd gene, which codes for phosphogluconate dehydratase, a protein
required for the catabolism of glucose and gluconate to
glyceraldehyde-3-phosphate and pyruvate via the Entner-Doudor-
off pathway [26,35,36]. The edd
2 mutant was phenotypically
similar to PAO1 in assays of swimming motility, twitching motility,
protease activity and Type III secretion system protein (PcrV and
ExoS) expression (Figure S3). In addition, lethality in a Drosophila
melanogaster infection model was also similar following edd
2 and
PAO1 infection (Figure S4). When edd
2 was used (Figure 5, B) to
inoculate the airways of ob/ob mice and db/db mice and their
respective littermate controls, neither showed increased bacterial
growth when compared to their normoglycemic controls (median
log CFU/mg of lung tissue=0, IQR 0 – 0 for control mice vs.
median=0, IQR 0 – 0.67 for hyperglycemic mice, p=0.5036). In
contrast, when the edd
2 mutant strain was injected into the
peritoneal cavity (a nutrient-rich environment) of mice, the LD50
was similar to that of PAO1 (Figure S5). These data show that
increased susceptibility to PAO1 infection in hyperglycemic mice
is due to the elevated glucose concentration in ASL, which can be
Figure 4. Low glucose concentration impairs growth of P.
aeruginosa in vitro. (A) Glucose concentration-dependent growth of P.
aeruginosa. M9 medium with glucose concentrations as shown (0, 0.5, 2,
8 and 24 mM) was inoculated with P. aeruginosa (PAO1) and OD600 was
followed. Data shown as mean 6 s.e.m. n=3. (B) Growth of P.
aeruginosa in ASL is nutrient-limited. ASL and M9 medium with and
without added glucose (20 mM) as shown were inoculated with PAO1.
OD600 was followed over time. Data shown as mean 6 s.e.m. n=3.
(***: p,0.0001 for ASL vs. ASL + glucose). (C) Growth of P. aeruginosa in
human airway epithelia is limited by ASL glucose concentration.
Cultures of human airway epithelia were inoculated apically with 2.3 or
3.3 log CFU of PAO1 in the absence (white bars) or presence (gray bars)
of added glucose (20 mM). After 24 h, apical bacteria were quantified.
Percentage of samples in which growth of bacteria occurred are shown.
n=5. (D) Facilitated diffusion transport in airway epithelia in vitro
impairs growth of P. aeruginosa. Cultures of human airway epithelia
were inoculated apically with 0.5, 1.5 or 2.5 log CFU of PAO1 after
incubation with apical vehicle (white bars) or phloretin (gray bars). After
24 h, apical bacteria were quantified. Percentage of samples in which
growth of bacteria occurred are shown. n=12. (*: p,0.05 for vehicle vs.
phloretin).
doi:10.1371/journal.pone.0016166.g004
Figure 5. Hyperglycemia promotes growth of P. aeruginosa in
the lungs of mice. (A and B) An intranasal inoculum (7.69 log CFU) of
PAO1 (A)o redd
2 (B) was given to ob/ob and db/db mice and their
respective littermate controls (ob/ob ctrl and db/db ctrl). After 6 hours,
lungs were homogenized for bacterial counts. n=5 mice per group.
(*: p,0.05, ns: p $ 0.05).
doi:10.1371/journal.pone.0016166.g005
Airway Glucose and Innate Immunity
PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e16166used by the bacteria as a nutrient source, and confirms that low
glucose concentration in the ASL is required for the antimicrobial
activity of airway epithelia in vivo.
Discussion
In this study, we describe a novel mechanism that allows human
airway epithelia to generate a transepithelial glucose concentration
gradient. Moreover, this gradient results in an ASL that contains a
low glucose concentration. Our studies suggest that this low
concentration of glucose plays an important role in limiting the
growth of bacteria and maintaining the sterility on the surface of
human airway epithelia and leads us to speculate that the
concentration of other carbon sources in ASL may also be low.
We propose a novel mechanism in human airway epithelia that
generates a transepithelial glucose concentration gradient by
expressing 2 distinct facilitated diffusion transporters in polarized
localizations. This is in contrast to mechanisms in epithelia of the
human ileum or alveolar epithelia in the distal lung, where Na
+-
glucose cotransport plays a central role in transepithelial glucose
transport. GLUT-1, which we observed in the basolateral
membrane, is the most ubiquitously expressed facilitated diffusion
glucose transporter in humans; it has a Km between 3 and 7 mM
and has a proposed function of cellular insulin-independent basal
glucose uptake [18,37]. GLUT-10, which we observed in the
apical membrane of human airway epithelia, has previously been
examined because of a potential link to Diabetes Mellitus Type 2,
but studies failed to prove an association [38–40]. Interestingly,
GLUT-10 has a very low Km of approximately 0.3 mM, the
lowest in the group of facilitated diffusion glucose transporters
[18,22]. This Km is very close to the glucose concentration in both
human ASL [10] and rat lung cells [41] (0.5 mM).
Glucose is exclusively supplied to the airways from circulating
blood, reaching the basolateral side of epithelial cells, where
uptake of glucose can occur. Glucose can reach the ASL through
both the paracellular and transcellular pathways at a specific rate,
but the epithelial cells have the capacity to absorb it through the
apical membrane at an equal or higher rate (Figure 3D).
What is the driving force that allows epithelial absorption of
glucose from both the apical and basolateral compartments? Our
data supports interesting conclusions. Intracellular glucose, under
normal conditions, is constantly phosphorylated by hexokinase in
an ATP-dependent reaction, creating flux into a chemical ‘‘fourth
compartment’’. This would maintain an intracellular non-
phosphorylated glucose concentration that is lower than that of
blood, and a glucose concentration gradient that can be the
driving force for basolateral uptake. Any glucose reaching the ASL
would therefore be absorbed at a rate that would keep it at
concentration equilibrium with intracellular non-phosphorylated
glucose (Figure 6, A). Data supporting this idea come from studies
performed in isolated lung cells grown in suspension, in which the
intracellular concentration of glucose was found to be ,0.5 mM
when the extracellular glucose was 5 mM or higher [41].
Disruption of this homeostatic mechanism could occur at
different levels. An increase in blood glucose concentration, such
as in diabetes mellitus, could result in an increased rate of glucose
flux into ASL with correspondingly increased glucose concentra-
tion (Figure 6, B). This could explain the increased rate of
ventilator-associated MRSA pneumonia [11] in ICU patients with
hyperglycemia and the poor outcomes in hyperglycemic patients
hospitalized for community acquired pneumonia [3]. This
mechanism could also be disrupted by fluctuations of tight
junction permeability (Figure 6, C), such as those induced by
hypersensitivity reactions, exposure to toxic particles, or other
inflammatory stimuli, including viral infections such as influenza
or the common cold, which have been shown to increase the risk
of bacterial pneumonia and correlate with detection of nasal
glucose [1,10,42–45]. Also, even though environmental exposures
to glucose are uncommon (confectioners lung), the presence of
sugars in formulations that are nebulized into the airway could
affect the homeostatic mechanism we have described. Finally,
disruption of apical transport of glucose –as shown in our in vitro
data– could impair generation of the glucose concentration
gradient (Figure 6, D). It has been shown that mutations in the
gene encoding GLUT-10 are responsible for Arterial Tortuosity
Syndrome [46,47], a rare autosomal recessive disorder, with a
phenotype characterized by arterial elongation, tortuosity and
aneurysms, and a high mortality rate (40% before the age of 5
years). The cause of early deaths has not been studied extensively,
but a lethal case of spontaneous bilateral Staphylococcus aureus
bronchopneumonia in a 4 year-old child has been reported [48].
The question of whether this infection was a consequence of
impaired glucose transport in the airways remains to be answered.
Figure 6. Alterations in transepithelial glucose transport. Diagram of transepithelial glucose transport under normal conditions (A),
hyperglycemia (B), increased tight junction permeability (C) or impaired apical glucose transporter function (D). Gray solid arrows represent glucose
uptake capacity across the apical (top) and basolateral (bottom) membranes. Dotted arrows represent transcellular bidirectional fluxes of glucose.
Arrow width and font size are modified in each figure according to the primary alteration in glucose transport rate and resulting basolateral and
apical concentration, respectively. GLUT-10 is present in the apical membrane and GLUT-1 is present in the basolateral membrane. Intracellular
glucose (G) is phosphorylated by hexokinase (HK) for subsequent glycolysis. G6P= glucose-6-phosphate.
doi:10.1371/journal.pone.0016166.g006
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eliminated, resulting in a sterile lung, or proliferate to cause
infection or colonization depends on host factors and the bacteria.
In the airways, multiple innate immune mechanisms have evolved
to rapidly kill, expel, or engulf bacteria. These diverse mechanisms
act within seconds (antimicrobials, cough) or minutes (mucociliary
clearance and phagocytes) and are most effective with small
inocula of bacteria. Abnormally high glucose concentration in the
ASL could both directly promote bacterial growth and impair
antimicrobials [49]. When bacteria are not eliminated, growth can
be exponential and virulence factors of pathogenic and non-
pathogenic bacteria can play a role. Thus, in the airways, the time-
dependent balance between bacterial killing and growth determine
the outcome. Our data suggest that carbon source deprivation in
airway surface liquid helps tip the balance towards airway sterility.
Supporting Information
Figure S1 Na
+-glucose cotransport activity is absent from well-
differentiated cultures of human airway epithelia. Short-circuit
current in cultures of human airway epithelia was studied in
Ussing chambers. Amiloride and bumetanide were added to
Ussing chamber solution, followed by glucose in the apical or
basolateral solution in increasing concentrations. Representative
tracings of 3 replicates are shown.
(TIFF)
Figure S2 Basolateral to apical (BL to AP) and apical to
basolateral (AP to BL) fluxes of L-[1-
14C]glucose (A) or 2-deoxy-d-
[1-
14C]glucose (B) were measured in intact pig tracheal epithelia
over 1 hour. Data shown as mean 6 s.e.m. n = 9 samples per
group. (***: p,0.0001, ns: p $ 0.05). (C) Basolateral (BL) and
apical (AP) uptake of 2-deoxy-d-[1-
14C]glucose (2-DOG) in intact
pig tracheal epithelia were measured over 1 hour. Data shown as
mean 6 s.e.m. n = 9 samples per group. (***: p,0.0001).
(D) Correlation of transepithelial electrical conductance at baseline
vs. transepithelial conductance of glucose in intact pig tracheal
epithelia. In the intact tracheal epithelia of pigs, bidirectional
fluxes of L-glucose were higher than in cultured human epithelia
and fluxes of 2-DOG occurred at similar rates in the presence of
uptake from both the apical and basolateral membranes. These
data indicate that glucose supplied to intact airway epithelia can
reach the ASL through the paracellular but not the transcellular
pathway. Moreover, the result suggests that intracellular phos-
phorylation of glucose resulting in a transepithelial concentration
gradient occurs at a higher rate in vivo compared to cultured cells.
(TIFF)
Figure S3 Swimming motility, twitching motility, protease
activity and Type III secretion system protein expression are
preserved in edd
2.( A) A swimming motility assay comparing
PAO1 and edd
2 was performed as described in [50]. Represen-
tative sample of n = 3 is shown. (B) A twitching motility assay
comparing PAO1 and edd
2 was performed as described in [51],
duplicate samples are shown. (C) Protease activity was character-
ized as described in [52], triplicate samples shown. (D) Expression
of PcrV and ExoS, which are Type III secretion system proteins,
was determined by using the method described in [53].
(TIFF)
Figure S4 edd
2 lethality is preserved in a D. melanogaster infection
model. Survival of D. melanogaster was monitored for 72 h after
inoculation of the abdominal cavity with PAO1 or edd
2 as
described in [54] (n=20).
(TIFF)
Figure S5 edd
2 lethality is preserved in a murine peritoneal
infection model. All experiments were reviewed and approved by
the Animal Care and Use Committee of the University of Iowa.
Male 6 to 8 week old C57B/J6 mice obtained from Harlan
Industries, Inc (Indianapolis, IN, USA) were used and were
allowed access to food and water ad libitum. Mice were
anesthetized with isoflurane and injected intraperitoneally with
3610
7 CFU of PAO1 or edd
2 in a volume of 100 mLH 2O. exsA
2
strain of P aeruginosa was used as a negative control. Mice were
carefully monitored and euthanized when end-point conditions
were met (moribund, distressed, and unable to eat or drink).
(TIFF)
Text S1 Supporting Information Methods.
(DOC)
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